Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 Years of clinical experience

European Journal of Oncology Nursing

Volumn 16, Issue 5, 2012, Pages 465-471

  Goossens, Godelieve Alice ^a,b   Stas, Marguerite ^a   Moons, Philip ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Advance practice nursing; Catheters; Functional outcomes; Indwelling; Neoplasms; Retrospective studies; Study

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ADVANCED PRACTICE NURSING; AGED; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CHI SQUARE DISTRIBUTION; CHILD; FEMALE; HUMAN; INDWELLING CATHETER; INFANT; INFUSION PUMP; MALE; MIDDLE AGED; NEOPLASM; NURSING; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ADVANCED PRACTICE NURSING; AGED; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFUSION PUMPS, IMPLANTABLE; MALE; MIDDLE AGED; NEOPLASMS; PATIENT CARE TEAM; RETROSPECTIVE STUDIES;

EID: 84869504050     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2011.11.006     Document Type: Article

References (29)

1. Bader S.G., Balke P., Jonkers-Schuitema C.F., Tas T.A., Sauerwein H.P. Evaluation of 6 years use of sodium hydroxide solution to clear partially occluded central venous catheters. Clinical Nutrition 2007, 26:141-144.
2. Bansal A., Binkert C.A., Robinson M.K., Shulman L.N., Pellerin L., Davison B. Impact of quality management monitoring and intervention on central venous catheter dysfunction in the outpatient chemotherapy infusion setting. Journal of Vascular and Interventional Radiology 2008, 19:1171-1175.
3. Baskin J.L., Pui C.H., Reiss U., Wilimas J.A., Metzger M.L., Ribeiro R.C., et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009, 374:159-169.
4. Caers J., Fontaine C., Vinh-Hung V., De Mey J., Ponnet G., Oost C., et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Supportive Care in Cancer 2005, 13:325-331.
5. Carlo J.T., Lamont J.P., McCarty T.M., Livingston S., Kuhn J.A. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. The American Journal of Surgery 2004, 188:722-727.
6. Goossens G.A., Stas M., Jerome M., Moons P. Systematic review: malfunction of totally implantable venous access devices in cancer patients. Support Care Cancer 2011, 19:883-898.
7. Goudreau K.A., Baldwin K., Clark A., Fulton J., Lyon B., Murray T., et al. A vision of the future for clinical nurse specialists: prepared by the National Association of Clinical Nurse Specialists, July 2007. Clinical Nurse Specialist 2007, 21:310-320.
8. Haire W.D. Techniques in dosing for thrombolysis of occluded central venous catheters. Techniques in Vascular and Interventional Radiology 2001, 4:127-130.
9. Haire W.D., Lieberman R.P. Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus. Journal of Parenteral and Enteral Nutrition 1992, 16:129-132.
10. Hardy G., Ball P. Clogbusting: time for a concerted approach to catheter occlusions?. Current Opinion in Clinical Nutrition & Metabolic Care 2005, 8:277-283.
11. Heye S., Maleux G., Goossens G.A., Vaninbroukx J., Jerome M., Stas M. Feasibility and safety of endovascular stripping of totally implantable venous access devices. Cardiovascular and Interventional Radiology 2011.
12. Kausche S., Nagel S.N., Teichgraber U. Interventional radiological imaging and treatment of port catheter dysfunctions. Rofo 2011, 183:260-266.
13. Krzywda E.A. Predisposing factors, prevention, and management of central venous catheter occlusions. Journal of Intravenous Nursing 1999, 22:S11-S17.
14. Lamont J.P., McCarty T.M., Stephens J.S., Smith B.A., Carlo J., Livingston S., et al. A randomized trial of valved vs nonvalved implantable ports for vascular access. Proceedings (Baylor University Medical Center) 2003, 16:384-387.
15. Mayo D.J. Fibrin sheath formation and chemotherapy extravasation: a case report. Supportive Care in Cancer 1998, 6:51-56.
16. Moll S., Kenyon P., Bertoli L., De M.J., Homesley H., Deitcher S.R. Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices. Journal of Clinical Oncology 2006, 24:3056-3060.
17. NAVAN Position statement, 1998. Tip location of peripherally inserted central catheters. JVAD 8-10.
18. Petersen J., Delaney J.H., Brakstad M.T., Rowbotham R.K., Bagley C.M. Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction. The American Journal of Surgery 1999, 178:38-41.
19. Rcn IV Therapy Forum Standards for Infusion Nursing 2010, Royal College of Nursing, London.
20. Registered Nurses' Association of Ontario Care and Maintenance to Reduce Vascular Access Complications, Revised Supplement 2008 Enclosed 2005, Registered Nurses' Association of Ontario, Toronto, Canada.
21. Schulmeister L. Management of non-infectious central venous access device complications. Seminars in Oncology Nursing 2010, 26:132-141.
22. Schulmeister L., Camp-Sorrell D. Chemotherapy extravasation from implanted ports. Oncology Nursing Forum 2000, 27:531-538.
23. Schummer W., Schummer C., Schelenz C. Case report: the malfunctioning implanted venous access device. British Journal of Nursing 2003, 12(210):212-220. 214.
24. Stephens L.C., Haire W.D., Kotulak G.D. Are clinical signs accurate indicators of the cause of central venous catheter occlusion?. Journal of Parenteral and Enteral Nutrition 1995, 19:75-79.
25. Surov A., Jordan K., Buerke M., Arnold D., John E., Spielmann R.P., et al. Port catheter insufficiency: incidence and clinical-radiological correlations. Onkologie 2008, 31:455-461.
26. Verhamme P., Jerome M., Goossens G., Devis J., Maleux G., Stas M. A pilot trial of microplasmin in patients with long-term venous access catheter thrombosis. The Journal of Thrombosis and Thrombolysis 2009, 28:477-481.
27. Wolosker N., Yazbek G., Munia M.A., Zerati A.E., Langer M., Nishinari K. Totally implantable femoral vein catheters in cancer patients. European Journal of Surgical Oncology 2004, 30:771-775.
28. Woodard W.T., Day E.D., Silver D. The fate of infused urokinase. Surgery 1970, 68:692-697.
29. Xiang D.Z., Verbeken E.K., Van Lommel A.T., Stas M., De W.I. Sleeve-related thrombosis: a new form of catheter-related thrombosis. Thrombosis Research 2001, 104:7-14.